Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation.
Pharmacogenetics and genomics 2014 Apr 24 (4): 211-9.
Senapati Sabyasachi, Singh Shalini, Das Mitashree, Kumar Ashok, Gupta Rajiva, Kumar Uma, Jain Sanjay, Juyal Ramesh C, Thelma B
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 11, 2019
- Content source: